EWA
XBIT icon

EverSource Wealth Advisors’s XBiotech XBIT Stock Holding History

EverSource Wealth Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17
Closed -$45 – 4466
2025
Q3 		$45 Sell
17
-14
-45% -$41 ﹤0.01% 4262
2025
Q2 		$92 Buy
31
+18
+138% +$52 ﹤0.01% 4138
2025
Q1 		$42 Buy
+13
New +$45 ﹤0.01% 3911

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EverSource Wealth Advisors's XBIT Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of XBiotech (XBIT) in Q4 2025, closing a stake of 17 shares — an estimated $45 sold.

EverSource Wealth Advisors first reported a position in XBIT in Q1 2025 and held it in 3 quarters. The position peaked at $92 in Q2 2025. 41 funds tracked by Wall St. Rank hold XBIT as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining XBiotech position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 17 XBiotech shares in Q4 2025, an estimated $45.
  • EverSource Wealth Advisors first reported a position in XBiotech in Q1 2025 and held it in 3 quarters.
  • EverSource Wealth Advisors's XBiotech position peaked at $92 in Q2 2025.
  • 41 funds tracked by Wall St. Rank held XBiotech as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.